Clinical trials
Trials in Mongolia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2010 | 4 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Unknown status | 18 |
| Recruiting | 2 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunitor LLC | 14 |
| Nakhia Impex LLC | 3 |
| Harvard School of Public Health (HSPH) | 2 |
| Mongolian National University of Medical Sciences | 2 |
| National Cancer Institute (NCI) | 2 |
| Phenox GmbH | 2 |
| Shanghai HEP Pharmaceutical Co., Ltd. | 2 |
| Bausch Health Americas, Inc. | 1 |
| Brigham and Women's Hospital | 1 |
| Columbia University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis | 4 |
| Tuberculosis, Multidrug-Resistant | 4 |
| Breast Neoplasms | 3 |
| COVID-19 | 3 |
| Aneurysm | 2 |
| Bites and Stings | 2 |
| Carcinoma, Hepatocellular | 2 |
| Cholangiocarcinoma | 2 |
| Hepatitis D | 2 |
| Intracranial Aneurysm | 2 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.